Introduction

This page provides a comprehensive analysis of the known insider trading history of Eric Drape. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Eric Drape has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Executive VP Global Operations 145,915
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Eric Drape. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Eric Drape as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-03-07 2024-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 55,226 145,915 60.90
2024-03-07 2024-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 22,576 90,689 33.14
2024-03-05 2024-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 33,512 77,928 75.45
2024-03-05 2024-03-03 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 24,900 44,416 127.59
2024-03-01 2024-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,815 9,701 -50.29 13.12 -128,734 127,238
2024-03-01 2024-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 19,515 19,516 1,951,500.00
2024-02-21 2024-02-16 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -173,261 1 -100.00 13.05 -2,261,905 13
2023-03-08 2023-03-07 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -4,699 173,262 -2.64 9.43 -44,302 1,633,497
2023-03-08 2023-03-06 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -1,566 177,961 -0.87 9.93 -15,552 1,767,313
2023-03-07 2023-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 22,576 179,527 14.38
2023-03-07 2023-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 33,512 156,951 27.15
2023-03-07 2023-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 11,940 123,439 10.71
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -23,888 111,499 -17.64 9.89 -236,171 1,102,346
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 47,598 135,387 54.22
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,797 87,789 -10.04 9.89 -96,859 867,935
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 19,514 97,586 24.99
2022-03-08 2022-03-07 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -11,334 78,072 -12.68 7.37 -83,494 575,133
2022-03-08 2022-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -22,576 67,728 -25.00
2022-03-08 2022-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 22,576 89,406 33.78
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 134,048 134,048
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -11,940 11,940 -50.00
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -32,518 0 -100.00
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,301 66,830 -8.62 7.48 -47,147 500,055
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 11,940 73,131 19.51
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -17,157 61,191 -21.90 7.48 -128,377 457,862
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 32,518 78,348 70.95
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -19,514 39,029 -33.33
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,797 45,830 -17.61 8.14 -79,769 373,157
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 19,514 55,627 54.04
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -6,568 0 -100.00
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -3,583 36,113 -9.03 9.06 -32,464 327,202
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 6,568 39,696 19.83
2022-02-10 2022-02-08 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 32,518 32,518
2021-05-25 2021-05-21 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -40,000 33,128 -54.70 11.01 -440,320 364,673
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -37,884 0 -100.00
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -19,804 73,128 -21.31 10.22 -202,413 747,427
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 37,884 92,932 68.82
2021-03-08 2021-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 90,304 90,304
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -11,940 23,880 -33.33
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,183 55,048 -10.10 10.58 -65,443 582,650
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 11,940 61,231 24.22
2021-03-02 2021-03-01 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,795 49,291 -16.58 10.85 -106,285 534,852
2021-03-02 2021-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -19,514 58,543 -25.00
2021-03-02 2021-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 19,514 59,086 49.31
2021-02-17 2021-02-16 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,079 39,572 -4.99 11.13 -23,135 440,361
2021-02-17 2021-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -3,926 0 -100.00
2021-02-17 2021-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 3,926 41,651 10.41
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 37,884 37,884
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -6,567 6,568 -50.00
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -14,527 37,725 -27.80 12.72 -184,797 479,896
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -3,452 52,252 -6.20 12.72 -43,913 664,692
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
A - Award 27,643 55,704 98.51
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 6,567 28,061 30.55
2020-03-03 2020-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 78,057 78,057
2020-02-20 2020-02-19 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -8,000 21,494 -27.12 12.51 -100,080 268,890
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -3,926 3,926 -50.00
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -13,090 0 -100.00
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -1,878 29,494 -5.99 12.14 -22,791 357,930
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,262 31,372 -16.64 12.14 -75,994 380,721
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 3,926 37,634 11.65
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 13,090 33,708 63.49
2020-02-13 2020-02-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 13,090 13,090
2020-02-11 2020-02-10 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -3,144 20,618 -13.23 12.24 -38,488 252,399
2020-02-11 2020-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -6,567 13,135 -33.33
2020-02-11 2020-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 6,567 23,762 38.19
2019-10-15 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
34,390
2019-10-15 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
34,390
2019-10-15 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
34,390
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)